Shield Therapeutics PLC Stock
Your prediction
Shield Therapeutics PLC Stock
Heavy losses for Shield Therapeutics PLC today as the stock fell by -€0.019 (-30.330%).
Pros and Cons of Shield Therapeutics PLC in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Shield Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | -30.330% | -10.949% | -10.294% | 17.308% | -41.905% | -42.453% | -87.602% |
| Card Factory plc | 3.140% | 5.076% | 12.195% | -24.453% | 8.947% | -19.455% | 23.582% |
| Pets At Home Group Ls 1 | -0.320% | 8.941% | 20.673% | -11.307% | 9.321% | -45.530% | -54.775% |
| Natural Grocers By Vit. Cot. | -2.110% | 11.719% | 5.926% | -12.805% | 33.645% | 157.658% | 202.646% |
News
Church & Dwight Q2 Earnings Call Highlights
Key Points
- Interested in Church & Dwight Co., Inc.? Here are five stocks we like better.
- Church & Dwight exceeded Q2 expectations, with net sales up 1.6%, organic sales up 5.8% and adjusted EPS
Exagen Q1 Earnings Call Highlights
Exagen (NASDAQ:XGN) reported record first-quarter revenue and reaffirmed its full-year outlook, as executives said growth in testing volume, improved reimbursement execution and expanding clinician
What Is the "Achilles Shield" and How Is Lockheed Martin Involved? Here's What Investors Need to Know.
Greece's air-defense capabilities will soon be getting an upgrade. That's the chief takeaway from the country's recent vote by the Special Permanent Parliamentary Committee on Armaments Programs and
